98 related articles for article (PubMed ID: 28465042)
1. High constitutive B7-H3 expression on human keratinocytes supports T cell immunity.
Quandt D; Fiedler E; Müller A; Marsch WC; Seliger B
J Dermatol Sci; 2017 Jul; 87(1):82-85. PubMed ID: 28465042
[No Abstract] [Full Text] [Related]
2. A B7-1-transfected human melanoma line stimulates proliferation and cytotoxicity of autologous and allogeneic lymphocytes.
Sulé-Suso J; Arienti F; Melani C; Colombo MP; Parmiani G
Eur J Immunol; 1995 Oct; 25(10):2737-42. PubMed ID: 7589065
[TBL] [Abstract][Full Text] [Related]
3. B7-H1 and B7-H3 are independent predictors of poor prognosis in patients with non-small cell lung cancer.
Mao Y; Li W; Chen K; Xie Y; Liu Q; Yao M; Duan W; Zhou X; Liang R; Tao M
Oncotarget; 2015 Feb; 6(5):3452-61. PubMed ID: 25609202
[TBL] [Abstract][Full Text] [Related]
4. [Splicing factor SC35 regulated the expression of B7-H3 in vitro].
Yi LX; Gao B; Gao F; Fu FQ; Zhang XG; Sun J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Aug; 28(8):815-7. PubMed ID: 22863587
[TBL] [Abstract][Full Text] [Related]
5. B7-H3 and B7-H4 expression in phyllodes tumors of the breast detected by RNA in situ hybridization and immunohistochemistry: Association with clinicopathological features and T-cell infiltration.
Kim GE; Kim NI; Park MH; Lee JS
Tumour Biol; 2018 Nov; 40(11):1010428318815032. PubMed ID: 30486739
[TBL] [Abstract][Full Text] [Related]
6. B7-H3 associated with tumor progression and epigenetic regulatory activity in cutaneous melanoma.
Wang J; Chong KK; Nakamura Y; Nguyen L; Huang SK; Kuo C; Zhang W; Yu H; Morton DL; Hoon DS
J Invest Dermatol; 2013 Aug; 133(8):2050-8. PubMed ID: 23474948
[TBL] [Abstract][Full Text] [Related]
7. Cloning and characterization of porcine 4Ig-B7-H3: a potent inhibitor of porcine T-cell activation.
Chen W; Hou Z; Li C; Xiong S; Liu H
PLoS One; 2011; 6(6):e21341. PubMed ID: 21738638
[TBL] [Abstract][Full Text] [Related]
8. B7-H abnormalities in melanoma and clinical relevance.
Seliger B
Methods Mol Biol; 2014; 1102():367-80. PubMed ID: 24258988
[TBL] [Abstract][Full Text] [Related]
9. PD-L1, B7-H3, and PD-1 expression in immunocompetent vs. immunosuppressed patients with cutaneous squamous cell carcinoma.
Varki V; Ioffe OB; Bentzen SM; Heath J; Cellini A; Feliciano J; Zandberg DP
Cancer Immunol Immunother; 2018 May; 67(5):805-814. PubMed ID: 29484464
[TBL] [Abstract][Full Text] [Related]
10. [Immunologic reaction-readiness in malignant melanoma].
Bickhardt R; Kunze J
Z Hautkr; 1974 Apr; 49(8):315-33. PubMed ID: 4599330
[No Abstract] [Full Text] [Related]
11. Cytotoxity of non-T versus T-lymphocytes from melanoma patients and healthy donors on short- and long-term cultured melanoma cells,
de Vries JE; Cornain S; Rumke P
Int J Cancer; 1974 Oct; 14(4):427-34. PubMed ID: 4549213
[No Abstract] [Full Text] [Related]
12. Non-small cell lung cancer induces an immunosuppressive phenotype of dendritic cells in tumor microenvironment by upregulating B7-H3.
Schneider T; Hoffmann H; Dienemann H; Schnabel PA; Enk AH; Ring S; Mahnke K
J Thorac Oncol; 2011 Jul; 6(7):1162-8. PubMed ID: 21597388
[TBL] [Abstract][Full Text] [Related]
13. B7-h4 expression in human melanoma: its association with patients' survival and antitumor immune response.
Quandt D; Fiedler E; Boettcher D; Marsch WCh; Seliger B
Clin Cancer Res; 2011 May; 17(10):3100-11. PubMed ID: 21378130
[TBL] [Abstract][Full Text] [Related]
14. The third group of the B7-CD28 immune checkpoint family: HHLA2, TMIGD2, B7x, and B7-H3.
Janakiram M; Shah UA; Liu W; Zhao A; Schoenberg MP; Zang X
Immunol Rev; 2017 Mar; 276(1):26-39. PubMed ID: 28258693
[TBL] [Abstract][Full Text] [Related]
15. Down-Regulation of Donor Kupffer Cell B7 Expression Reduced Recipient Lymphocyte Activation and Secretion of Interleukin-2 In Vitro.
Li T; Zhu JY; Wang FS; Leng XS
Transplant Proc; 2015 Dec; 47(10):2985-90. PubMed ID: 26707326
[TBL] [Abstract][Full Text] [Related]
16. B7-H3 contributes to the metastatic capacity of melanoma cells by modulation of known metastasis-associated genes.
Tekle C; Nygren MK; Chen YW; Dybsjord I; Nesland JM; Maelandsmo GM; Fodstad O
Int J Cancer; 2012 May; 130(10):2282-90. PubMed ID: 21671471
[TBL] [Abstract][Full Text] [Related]
17. [Eukaryotic expression of recombinant B7-H3Ig protein and its effects on T cells].
Chen L; Zhang G; Zhu Y; Zhang X
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Jan; 29(1):27-30. PubMed ID: 23294715
[TBL] [Abstract][Full Text] [Related]
18. [The reaction of the T-immunity system in patients with malignant skin melanoma and stomach cancer to active nonspecific immunotherapy].
Glinkina LS; Bruvere RZh
Vopr Onkol; 1992; 38(6):659-66. PubMed ID: 1300766
[TBL] [Abstract][Full Text] [Related]
19. Murine B7-H3 is a negative regulator of T cells.
Prasad DV; Nguyen T; Li Z; Yang Y; Duong J; Wang Y; Dong C
J Immunol; 2004 Aug; 173(4):2500-6. PubMed ID: 15294965
[TBL] [Abstract][Full Text] [Related]
20. Evidence for tumor-specific immunity in human malignant melanoma.
Nagel GA; Piessens WF; Stilmant MM; Lejeune F
Eur J Cancer (1965); 1971 Feb; 7(1):41-7. PubMed ID: 5576728
[No Abstract] [Full Text] [Related]
[Next] [New Search]
